Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Prostatic Neoplasms 1Bone Neoplasms 1

Interventions

Ibandronic Acid 8Zoledronic Acid 5Irinotecan 3Temozolomide 2Radiation 2Doxorubicin 2Denosumab 2Cyclophosphamide 2Cryotherapy 2Cryosurgery 2selinexor 1saracatinib 1robatumumab 1ridaforolimus 1radium Ra 223 dichloride 1pegfilgrastim 1palbociclib 1liposomal doxorubicin 1cc-486 1anlotinib 1Vincristine 1Topotecan 1Taxes 1Radiotherapy 1Quality of Life 1Pregabalin 1Patient Reported Outcome Measures 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Bone Neoplasms × Etoricoxib × Clear all
NCT00095017 2022-02-16

Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)

Organon and Co

Phase 2 Withdrawn
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡